[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
Articles Archive::
Guide for Authors::
For Reviewers::
Ethical Statements::
Registration::
Site Facilities::
Contact us::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Copyright Policies

 

AWT IMAGE

 

..
Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

..
:: Volume 6 - The Spring Supplement of Shefaye Khatam 1 - ::
Shefaye Khatam 2018, 6 - The Spring Supplement of Shefaye Khatam 1 -: 168-168 Back to browse issues page
P137: Stem Cell Therapy in Alzheimer’s Disease
Sepideh Mansoori Majoofardi * , Saman Esmaeilnejad , Zahra Behrooznia
a. Faculty of Medicine‚ Mashhad Branch, Islamic Azad University‚ Mashhad, Iran b. Gastric Cancer Research Group‚ Mashhad University of Medical Sciences, Mashhad‚ Iran , sepideh.mansoori91@gmail.com
Abstract:   (2739 Views)
Alzheimer disease (AD) is a progressive neurodegenerative brain disorder which plays an important role in neural cell destruction and as a result it causes memory loss in the patients. This disease is also the most common type of dementia which doesn’t completely respond to medical treatments so no certain cure is available. Recent studies show the advantages of using stem cells (SCs) in treatment of AD. This cells has been used in animal models of AD and they have been effective in control and also treating AD symptoms in this animals. Embryonic stem cells, mesenchymal stem cells, and neural stem cells are the most common SCs that have been used in AD treatment. This cells could be transplanted to the animal body intravenously and locally. There is a hypothesis that the transplanted cells probably stimulate neurogenesis damaged pats of Alzheimer's patient brains that causes improvements in patient’s cognitive functions. Another hypothesis says that this cells divide into neuronal precursor cells, neurons and glia in damaged areas and integrate into the brain circuits. SCs also could be used as a carriers for effective therapeutic compounds including Neprilysin, Plasmin and Cathepsin B which will reduce the Beta-amyloids in mice brains. With the advancements of the technology of SCs and the ability of transforming SCs to different types of neurons of central nervous system, many successes in AD treatment are foreseeable. There are a huge number of researchers who try to delay the disease progression and also regenerate the damaged neural cells by this cells. Despite challenges ahead, we hope that efforts of this growing research area will solve the problems ahead and some day may apply these therapeutic approach for treatment of AD.
Keywords: Alzheimer Disease, Stem Cell, Neurodegenerative Disease
Full-Text [PDF 237 kb]   (985 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mansoori Majoofardi S, Esmaeilnejad S, Behrooznia Z. P137: Stem Cell Therapy in Alzheimer’s Disease. Shefaye Khatam 2018; 6 (S1) :168-168
URL: http://shefayekhatam.ir/article-1-1617-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6 - The Spring Supplement of Shefaye Khatam 1 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 45 queries by YEKTAWEB 4645